New Partnership Aims to Unlock the Secrets of Mental Health Data

NASHVILLE, Tenn. and PHILADELPHIA, Penn. – June 16, 2026 – In a move poised to reshape mental health research, data specialist Behavioral Health Insights (BHI) and technology leader HealthVerity today announced a strategic partnership. The collaboration is designed to tackle one of the most persistent challenges in healthcare: the fragmented and clinically shallow nature of behavioral health data. By combining BHI's deep, longitudinal patient records with HealthVerity's privacy-first data linkage technology, the alliance aims to create a comprehensive, research-ready view of mental health that has long been out of reach for scientists, pharmaceutical firms, and policymakers.

The Great Data Divide in Mental Health

For decades, progress in understanding and treating Central Nervous System (CNS) and mental health disorders has been hampered by a fundamental data problem. Unlike oncology or cardiology, where standardized lab values, imaging results, and clear biomarkers create a wealth of structured data, the behavioral health landscape has been a patchwork of isolated systems, narrative-heavy notes, and inconsistent reporting standards. This data divide has created significant hurdles for real-world evidence (RWE) generation.

Historically, researchers have often relied on insurance claims data, which provides a broad but shallow picture. A claim can confirm a diagnosis was made or a prescription was filled, but it reveals little about the context of that care. It misses critical details on symptom severity, patient-reported outcomes, therapeutic progress, or the social determinants affecting a patient's journey. This lack of clinical depth makes it incredibly difficult to assess treatment effectiveness, identify patient subtypes, or develop novel therapies with confidence.

“Behavioral health data is uniquely complex, and too often the clinical detail needed for meaningful research gets lost,” said Reyna Klesh, Senior Director of RWD Operations at Behavioral Health Insights. “Our focus is on delivering behavioral health data that accurately reflects real‑world care, so researchers can study outcomes, severity, and treatment patterns with confidence.”

This new partnership directly confronts this challenge by moving beyond the limitations of claims and tapping into a richer source: two and a half decades of curated Electronic Medical Record (EMR) data.

Forging a New Link: Technology Meets Clinical Depth

The power of this partnership lies in the complementary strengths of the two companies. Behavioral Health Insights brings an unparalleled asset to the table: a dataset built from 25 years of longitudinal EMR data sourced from over 2,000 behavioral health and mental health agencies across 49 states. This repository contains the anonymized records of 16.7 million unique patients across more than 654 million encounters, offering a granular, clinically rich view of real-world mental healthcare delivery.

However, data, no matter how rich, is most powerful when it can be connected. This is where HealthVerity’s technology becomes the critical enabler. The company is a leader in privacy-protected data exchange, operating one of the nation's largest healthcare data ecosystems. Its core technology revolves around a process called tokenization. In essence, HealthVerity replaces all personally identifiable information (PII) with a unique, encrypted, and irreversible token—the HealthVerity ID (HVID). This HVID acts as a universal key, allowing researchers to link a patient's records across different datasets—such as BHI’s EMR data, pharmacy claims, lab results, and hospital records—without ever exposing sensitive personal information.

This technical bridge allows for the creation of a comprehensive, 360-degree view of a patient’s journey. For the first time on a national scale, researchers can connect deep behavioral health insights with a patient's broader medical history, enabling analyses that were previously impossible.

“Pharmaceutical companies need behavioral health evidence that can stand up to real-world scrutiny and integrate seamlessly with broader research efforts,” noted Benjamin Sacchetti, Vice President of Partnerships and Business Development at HealthVerity. “By pairing Behavioral Health Insights’ deep behavioral health data with privacy-protected data connectivity, we’re helping life sciences teams generate more complete evidence and support smarter, faster decision-making.”

Navigating the Privacy Minefield

Nowhere are the stakes for data privacy higher than in mental health. The information contained within behavioral health records is intensely personal, and the potential for stigma and discrimination necessitates the highest standards of protection. The regulatory landscape, governed by HIPAA and often stricter state-level laws, reflects this sensitivity, with special protections for materials like psychotherapy notes.

This partnership's 'privacy-first' architecture is central to its viability and ethical standing. The use of tokenization and de-identification is not merely a compliance feature; it is the foundational principle that allows for the ethical use of this sensitive data for the public good. By ensuring that the HVID token cannot be reverse-engineered to reveal a patient's identity, the platform allows for robust analysis while safeguarding individual privacy. This approach effectively balances the urgent need for better research with the non-negotiable right to patient confidentiality, a critical tightrope walk in the world of big data and healthcare.

This secure framework is essential for building trust not only with regulators but also with patients and advocacy groups, ensuring that the pursuit of innovation does not come at the cost of personal privacy.

Reshaping the RWE Landscape and Future Applications

The implications of this collaboration extend across the healthcare ecosystem. While the RWD market is crowded with players offering large-scale data, this partnership carves out a vital niche by focusing on clinically rich behavioral data—a historically underserved segment. By combining this specialized dataset with a best-in-class linkage platform, BHI and HealthVerity are creating an offering that is differentiated and desperately needed.

For pharmaceutical companies, the potential is immense. They can now design more effective clinical trials for CNS drugs, better understand long-term treatment outcomes, and identify patient populations that respond best to certain therapies. This could significantly accelerate the development and approval of new medications for conditions like depression, anxiety, schizophrenia, and bipolar disorder.

For federal agencies and public health organizations, the platform offers a powerful new tool for monitoring mental health trends, assessing the impact of policy interventions, and directing resources to where they are needed most. For academic researchers, it opens up a new frontier of inquiry into the complex interplay of mental and physical health.

Ultimately, this partnership represents a pivotal shift from disconnected, shallow data to integrated, actionable intelligence. By providing a clearer, more complete picture of the patient journey, this initiative has the potential to fuel a new wave of innovation in mental healthcare, transforming how we understand, treat, and manage mental illness on a global scale.